Veterinary Medicines

Lactovac Suspension for injection

Not authorised
  • Escherichia coli, serotype O9:K35 (fimbrial adhesin F5 and F41), strain S1091/83, Inactivated
  • Bovine coronavirus, strain 800, Inactivated
  • Bovine rotavirus A, strain Holland, Inactivated
  • Bovine rotavirus A, strain 1005/78, Inactivated
Download as PDF

Product identification

Medicine name:
Lactovac Suspension for injection
Lactovac Suspension injectable
Active substance:
  • Escherichia coli, serotype O9:K35 (fimbrial adhesin F5 and F41), strain S1091/83, Inactivated
  • Bovine coronavirus, strain 800, Inactivated
  • Bovine rotavirus A, strain Holland, Inactivated
  • Bovine rotavirus A, strain 1005/78, Inactivated
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Escherichia coli, serotype O9:K35 (fimbrial adhesin F5 and F41), strain S1091/83, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Bovine coronavirus, strain 800, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Bovine rotavirus A, strain Holland, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Bovine rotavirus A, strain 1005/78, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Revoked
Authorised in:
  • Luxembourg
Package description:
  • Type I glass vial containing 5 ml. The glass vial is closed with a type I rubber stopper, sealed with an aluminium crimp cap. Cardboard box with 10 glass vials of 1 dose (5 ml).
  • Type I glass vial containing 25 ml. The glass vial is closed with a type I rubber stopper, sealed with an aluminium crimp cap. Cardboard box with 1 glass vial of 5 doses (25 ml).

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Ministry Of Health And Social Security
Authorisation number:
  • V 087/91/11/0342
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0417/001